• Overview
  • Eligibility
  • More info
  • Locations

Smoking Cessation Intervention for Women With HIV/AIDS (NCT02898597)

As people with HIV/AIDS live longer, the burden of non-AIDS-related health problems such as cardiovascular diseases and cancers on these people have consistently increased. Smoking is one of the major contributing factors to these health problems and rates of cigarette smoking in this group are substantially higher than those of the general population: 40-70% vs. 17-10%. Especially, women living with HIV/AIDS seem to be more susceptible to the negative consequence of smoking than their male counterparts. They are also less likely to see tobacco dependence treatment for dual stigma associated with both conditions: HIV infection and nicotine addiction. This is a pilot study to develop smoking cessation intervention for these women.
  • Behavioral: Cognitive Behavioral Therapy
    Receive cognitive behavioral cessation counseling
    Ages eligible for Study
    18 Years to 75 Years
    Genders eligible for Study
    Female
    Accepts Healthy Volunteers
    No
    Inclusion Criteria:
    • English speaking
    • Diagnosis of HIV infection
    • Age 18 or older
    • Smoking at least 5 cigarettes a day
    • Having access to a mobile-phone with WiFi connection
    • Willing to quit smoking within the next 4 weeks
    Exclusion Criteria:
    • Inability to speak English
    • Involvement in another cessation program
    • Being pregnant or lactating
    • Having an active skin disease
    • History of serious mental illnesses (e.g., schizophrenia and bipolar disorder)
    • Serious alcohol use problem
    • Use of any illegal substances excluding marijuana
    Women are at high risk of becoming HIV positive due to biological vulnerabilities, low socioeconomic status, dominant sexual practices of males and epidemiological factors [1-3]. For example, the risk of being infected with HIV during unprotected sex is two to four times greater for women than for men [4]. With the use of combined antiretroviral therapies, these women now live longer than ever before which now faces the healthcare community with the need for evolving understanding of HIV and aging. However, the burden of non-AIDS related health problems such as cardiovascular diseases and cancers on people living with HIV/AIDS while aging has considerably increased [5, 6]. Smoking is one of the major contributing factors to these health problems. Rates of current cigarette smoking are substantially higher among people living with HIV/AIDS than the general population: 40-75% versus 19% [6]. Women smokers living with HIV have a 36% higher risk for developing AIDS and 53% higher mortality when compared to non-smoking women with HIV [6]. This study is a pilot randomized controlled trial (RCT) testing the feasibility and acceptability of a videoconferencing smoking cessation intervention (video arm) for women with HIV in comparison with a telephone-based smoking cessation intervention (telephone arm). Both arms will receive 8, 30-minute weekly cessation counseling sessions plus 8-week nicotine replacement therapy. Participants will be followed up at 1, 3 and 6 months from the target quit day. Self-reported abstinence will be verified with a saliva cotinine test using an Nicotine Alert test strip and the testing process will be monitored via mobile-phone video call.

    1 locations

    United States (1)
    • University Massachusetts Boston
      recruiting
      Boston, Massachusetts, United States, 02125
    Status:
    recruiting
    Type:
    Interventional
    Phase:
    -
    Start:
    31 May, 2016
    Updated:
    19 September, 2017
    Participants:
    50
    Apply
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!